The U.S. Food and Drug Administration (FDA) will hold a free public workshop to discuss technical challenges and solutions for 3D printing of medical devices, including the technical assessments to be considered for evaluation of future 3D printed devices. The FDA said it would like input regarding technical assessments that should be considered for additively manufactured devices in order to provide a transparent evaluation process for future submissions. The meeting, called “Additive Manufacturing of Medical Devices: An Interactive Discussion on the Technical Considerations of 3D Printing,” will be held October 8-9, 2014, at the FDA White Oak Campus in Silver Spring, Maryland, as a forum for the FDA, medical device manufactures, additive manufacturing companies, and academia.
The meeting will begin at 8 a.m. and will also be available via webcast. Registration for in-person or webcast attendance must be completed through the FDA website, on the workshop and conferences (medical devices) page, before the close of business on September 30. There is no fee to register and registration will be on a first-come, first-served basis due to limited seating.
